These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 974989)

  • 1. Phase I studies with Baker's Antifol (BAF) (NSC 139105).
    Rodriguez V; Gottlieb J; Burgess MA; Livingston R; Wheeler W; Spitzer G; Bodey GP; Blumenschein GR; Freireich EJ
    Cancer; 1976 Aug; 38(2):690-4. PubMed ID: 974989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 study with Baker's Antifol in solid tumors.
    Rodriguez V; Richman SP; Benjamin RS; Burgess MA; Murphy WK; Valdivieso M; Banner RL; Gutterman JU; Bodey GP; Freireich EJ
    Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of Baker's antifol in advanced colorectal cancer.
    Padilla F; Correa J; Buroker T; Vaitkevicius VK
    Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
    Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH
    Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of Baker's antifol in metastatic sarcoma.
    Thigpen JT; O'Bryan RM; Benjamin RS; Coltman CA
    Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma.
    McCreary RH; Moertel CG; Schutt AJ; O'Connell MJ; Hahn RG; Reitemeier RJ; Rubin J; Frytak S
    Cancer; 1977 Jul; 40(1):9-13. PubMed ID: 141977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate.
    Hall SW; Tenczynski TF; Benjamin RS; Burgess MA; Valdivieso M; Loo TL; Bodey GP
    Cancer Chemother Pharmacol; 1978; 1(3):139-44. PubMed ID: 373915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
    Bukowski RM; LoBuglio A; McCracken J; Pugh R
    Cancer Treat Rep; 1980; 64(12):1387-8. PubMed ID: 7471126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemistry of dihydrofolate reductase inhibitor antitumor agents: molecular structure of "Baker's antifol" (NSC 139105, triazinate) and "insoluble Baker's antifol" (NSC 113423).
    Camerman A; Smith HW; Camerman N
    Biochem Biophys Res Commun; 1978 Jul; 83(1):87-93. PubMed ID: 697826
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix.
    Arseneau JC; Bundy B; Dolan T; Homesley H; DiSaia PJ
    Am J Clin Oncol; 1982 Feb; 5(1):61-4. PubMed ID: 6211087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole.
    Bedikian AY; Valdivieso M; Mavligit GM; Burgess MA; Rodriguez V; Bodey GP
    Cancer; 1978 Nov; 42(5):2169-76. PubMed ID: 363254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baker's antifol in children with late-stage acute lymphocytic leukemia.
    Nitschke R; Vietti T; Ragab A; Dyment P
    Cancer Treat Rep; 1978 Dec; 62(12):2109-10. PubMed ID: 376130
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group study.
    Arseneau JC; Bundy B; Homesley H; Beecham J
    Invest New Drugs; 1983; 1(2):185-8. PubMed ID: 6236163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
    Bruckner HW; Lokich JJ; Stablein DM
    Cancer Treat Rep; 1982 Sep; 66(9):1713-7. PubMed ID: 7116348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DNA synthesis in normal and malignant human cells by triazinate (Baker's antifol) and methotrexate.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1976 Oct; 36(10):3659-64. PubMed ID: 953990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
    Calvert AH; Alison DL; Harland SJ; Robinson BA; Jackman AL; Jones TR; Newell DR; Siddik ZH; Wiltshaw E; McElwain TJ
    J Clin Oncol; 1986 Aug; 4(8):1245-52. PubMed ID: 3734849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I studies of trimetrexate using single and weekly dose schedules.
    Huan SD; Legha SS; Raber MN; Krakoff IH
    Invest New Drugs; 1991 May; 9(2):199-206. PubMed ID: 1831442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pharmacological evaluation of triazinate in humans.
    Skeel RT; Cashmore AR; Sawicki WL; Bertino JR
    Cancer Res; 1976 Jan; 36(1):48-54. PubMed ID: 1248009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of pentamethylmelamine.
    Ajani JA; Cabanillas FF; Bodey GP
    Cancer Treat Rep; 1982 May; 66(5):1227-8. PubMed ID: 6805950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.